scispace - formally typeset
C

Cara Lunn Shirai

Researcher at Washington University in St. Louis

Publications -  21
Citations -  453

Cara Lunn Shirai is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Haematopoiesis & Gene. The author has an hindex of 6, co-authored 15 publications receiving 343 citations.

Papers
More filters
Journal ArticleDOI

Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome

TL;DR: It is found that haematopoietic cells expressing mutant U2AF1(S34F), including primary patient cells, have an increased sensitivity to in vitro sudemycin treatment relative to controls, suggesting a potential for treating haem atological cancers harbouring U2 AF1 mutations with pre-mRNA splicing modulators like sudemies.
Journal ArticleDOI

Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib

TL;DR: Ruxolitinib was an effective salvage therapy for relapsed/refractory secondary hemophagocytic lymphohistiocytosis and the need for intensive chemotherapy or allogeneic transplant in secondary HLH was eliminated.
Journal ArticleDOI

Knockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cells.

TL;DR: Findings indicate that reduced levels of HSPA9 may contribute to TP53 activation and increased apoptosis observed in del(5q)-associated MDS.
Journal ArticleDOI

Sequencing-Based Measurable Residual Disease Testing in Acute Myeloid Leukemia.

TL;DR: This review focuses on the use of NGS-based MRD detection in AML, including basic methodologies and clinical applications.